The nutrition startup will use the fresh funding to advance research-led product development, introduce patented nutrition formats and build on its reported 300% growth in FY26.
Ace Blend, an Indian nutrition startup, has raised $9.91 million in a Series A2 funding round led by 3one4 Capital, with existing investor Fireside Ventures increasing its investment. Fireside Ventures had previously led the company’s $3.3 million pre-Series A round.
The fresh capital will support research-led product development and the launch of new nutrition formats as the company looks to expand its science-backed product portfolio. Ace Blend claims it grew 300% in FY26, while more than 46% of its customers returned to make repeat purchases, indicating strong customer retention.
Founded by Shivam Hingorani, Ace Blend began selling its products in 2018. Saif Mehkri joined as co-founder in 2022, bringing nearly three decades of experience in the nutrition industry. The company operates an integrated supply chain covering ingredient sourcing, formulation and manufacturing.
Ace Blend develops nutritional products using a research-led approach, with a focus on clinical evidence, nutrient forms, dosages and delivery methods. Its portfolio addresses several health needs, including heart health, immunity, sleep, recovery and brain health.
The company collaborates with global ingredient suppliers DSM and TCI, which have granted it exclusive rights in India to certain technologies. Its products are developed by an in-house clinical team and recommended by a network of more than 400 doctors.
Clinical validation and automated testing are conducted independently by accredited laboratories in Europe, forming part of the company’s approach to product development. Ace Blend also holds issued patents for new nutrition formats designed for everyday use.
The startup expects to introduce its first patented-format products in the fourth quarter of FY27. These launches will mark a further step in its effort to translate nutrition research into products designed for regular consumption.
With fresh funding, reported growth of 300% in FY26 and a repeat-purchase rate exceeding 46%, Ace Blend is positioning research and product innovation at the centre of its expansion strategy. Its next phase will focus on developing new formats while building on its existing portfolio across multiple health categories.
Source: Based on publicly available reporting, with additional editorial adaptation and analysis.
